From SBA 7(a) loans to seller notes, understand the capital structures that work for veterinary practice acquisitions in the $1M–$5M revenue range.
Animal hospitals trade at 4–7x EBITDA, making financing structure a critical deal variable. SBA lending remains the dominant path for individual buyers, while PE consolidators deploy equity and earnouts. A well-structured capital stack reduces day-one cash burden, supports DEA and licensing transition costs, and funds deferred equipment replacement common in independent practices.
The most common financing tool for individual veterinarian-buyers acquiring practices under $5M revenue. Covers goodwill, equipment, working capital, and in some cases real estate within a single loan structure.
Pros
Cons
The selling veterinarian carries a subordinated note, typically 5–15% of purchase price, bridging the gap between SBA financing and total deal value. Often paired with a 1–3 year employment or consulting agreement.
Pros
Cons
Regional or national veterinary platforms such as National Veterinary Associates or regional roll-ups acquire practices using equity and debt, often structuring earnouts tied to 2-year EBITDA performance for the selling veterinarian.
Pros
Cons
$2,500,000 animal hospital with $400K EBITDA (6.25x multiple), two associate vets on staff, no real estate included
Purchase Price
Approximately $21,500–$23,000/month on SBA loan at 10.5% over 10-year term; seller note payments deferred 24 months per SBA standby requirement
Monthly Service
Approximately 1.35–1.45x DSCR based on $400K EBITDA against ~$260K annual SBA debt service; meets standard SBA lender minimum of 1.25x
DSCR
SBA 7(a) loan: $2,125,000 (85%) | Seller note on standby: $125,000 (5%) | Buyer equity injection: $250,000 (10%)
Yes, but most SBA lenders require a licensed veterinarian as the clinical operator or co-borrower. Non-DVM buyers typically need a licensed veterinary partner with an equity stake to satisfy lender and state corporate practice of veterinary medicine requirements.
DEA registration is practice-specific and non-transferable. Buyers must apply for a new DEA registration before closing to legally dispense controlled substances. Lenders and buyers should budget 4–8 weeks for DEA approval and structure closing accordingly to avoid operational gaps.
Most SBA lenders require a minimum 1.25x DSCR, which for a 10-year SBA loan typically requires EBITDA margins of 18–22% or higher. Practices with margins below 15% will face scrutiny and may require additional buyer equity or a larger seller note.
A seller note is a fixed debt obligation repaid on a schedule. A consolidator earnout is contingent on post-close EBITDA performance — upside potential exists but payment is not guaranteed. Sellers should negotiate earnout caps, clear EBITDA definitions, and audit rights before accepting consolidator offers.
More Animal Hospital Guides
DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers